|
230 Park Avenue |
|
|
E-Mail: [email protected] |
51 John F. Kennedy Parkway www.ssbb.com |
|
February 13, 2018 |
|
|
Draft Registration Statement |
Confidential Submission |
Re: |
Confidential Submission of Draft Registration Statement on Form S-l |
Dear Ladies and Gentlemen:
On behalf of Y-mAbs Therapeutics, Inc., a Delaware corporation (the Company), we hereby confidentially submit the Companys draft Registration Statement on Form S-1 (the Registration Statement), pursuant to Title I, Section 106 under the Jumpstart Our Business Startups Act (the JOBS Act) and Section 24(b)(2) of the Securities Exchange Act of 1934, as amended, for non-public review by the staff of the Securities and Exchange Commission (the Commission). The Registration Statement submitted herewith relates to the initial public offering of the Companys common stock, $0.0001 par value per share.
The Company is an emerging growth company within the meaning of the JOBS Act.
We hereby confirm, on behalf of the Company, a formal filing of the Companys Registration Statement will be made at a later date, which in no event will be later than fifteen (15) days before the Company commences its road show.
Please direct all notices and communications with respect to this confidential submission to each of the following:
Y-mAbs Therapeutics, Inc.
Attention: Thomas Gad, Founder, Chairman and President
750 Third Avenue
9th Floor
New York, NY 10017
Telephone: (212) 847-9841
with a copy to:
Satterlee Stephens LLP
Attention: Dwight A. Kinsey, Esq.
230 Park Avenue
New York, NY 10169
Telephone: (212) 818-9200
Facsimile: (212) 818-9607
If you have any questions or comments concerning this submission or require any additional information, please do not hesitate to contact me at (212) 404-8727 or Rina R. Patel of my office at (212) 404-8736.
|
Very truly yours, |
|
|
|
/s/ Dwight A. Kinsey |
|
Dwight A. Kinsey |